Drug
Istradefylline
Istradefylline: highest development phase Phase 3, developed by Kyowa Kirin. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Kyowa Kirin
Trials
| Drug | Phase | Indication |
|---|---|---|
| Istradefylline ( KW-6002) NCT00199368 | Phase 3 | Parkinson's Disease |
| Istradefylline NCT00455507 | Phase 2 | Parkinson's Disease |
| Istradefylline 40 mg NCT02174250 | Phase 1 | Parkinson's Disease |
Latest
No recent events.
Follow Istradefylline on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.